Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lawrence

Showing results (441-450 of 534) with videos related to

Pageof 54
Sort By:
Familial Cancer|October 23, 2010
Inherited germline TP53 mutation encodes a protein with an aberrant C-terminal motif in a case of pediatric adrenocortical tumorEmilia M Pinto, Raul C Ribeiro, Gad B Kletter, et al.
Radiology|July 1, 1983
Clinical intra-arterial digital subtraction imaging. Use of small volumes of iodinated contrast material or carbon dioxideF J Miller, D E Mineau, P R Koehler, et al.
The Annals of Pharmacotherapy|August 31, 2012
A systematic comparison of cockcroft-gault and modification of diet in renal disease equations for classification of kidney dysfunction and dosage adjustmentEun Jung Park, Kunyi Wu, Zenghui Mi, et al.
BMC Public Health|December 17, 2013
Reducing disease burden and health inequalities arising from chronic disease among indigenous children: an early childhood caries intervention in Aotearoa/New ZealandJohn R Broughton, Joyce Te H Maipi, Marie Person, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 29, 2010
The effects of EPA, DHA, and aspirin ingestion on plasma lysophospholipids and autotaxinR C Block, R Duff, P Lawrence, et al.
Cancer|August 13, 2015
Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanomaElizabeth I Buchbinder, Jeffrey A Sosman, Donald P Lawrence, et al.
Oncoimmunology|November 20, 2013
BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytesZachary A Cooper, Dennie T Frederick, Vikram R Juneja, et al.
Annals of Neurology|February 23, 2020
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing SpectrumDivyanshu Dubey, William S David, Kerry L Reynolds, et al.
Cancer Research Communications|April 29, 2024
A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal MelanomaElizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, et al.
Seminars in Arthritis and Rheumatism|November 10, 2018
Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experienceMeghan J Mooradian, Mazen Nasrallah, Justin F Gainor, et al.
Pageof 54

Showing results (441-450 of 534) with videos related to

Sort By:
Pageof 54
Familial Cancer|October 23, 2010
Inherited germline TP53 mutation encodes a protein with an aberrant C-terminal motif in a case of pediatric adrenocortical tumorEmilia M Pinto, Raul C Ribeiro, Gad B Kletter, et al.
Radiology|July 1, 1983
Clinical intra-arterial digital subtraction imaging. Use of small volumes of iodinated contrast material or carbon dioxideF J Miller, D E Mineau, P R Koehler, et al.
The Annals of Pharmacotherapy|August 31, 2012
A systematic comparison of cockcroft-gault and modification of diet in renal disease equations for classification of kidney dysfunction and dosage adjustmentEun Jung Park, Kunyi Wu, Zenghui Mi, et al.
BMC Public Health|December 17, 2013
Reducing disease burden and health inequalities arising from chronic disease among indigenous children: an early childhood caries intervention in Aotearoa/New ZealandJohn R Broughton, Joyce Te H Maipi, Marie Person, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 29, 2010
The effects of EPA, DHA, and aspirin ingestion on plasma lysophospholipids and autotaxinR C Block, R Duff, P Lawrence, et al.
Cancer|August 13, 2015
Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanomaElizabeth I Buchbinder, Jeffrey A Sosman, Donald P Lawrence, et al.
Oncoimmunology|November 20, 2013
BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytesZachary A Cooper, Dennie T Frederick, Vikram R Juneja, et al.
Annals of Neurology|February 23, 2020
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing SpectrumDivyanshu Dubey, William S David, Kerry L Reynolds, et al.
Cancer Research Communications|April 29, 2024
A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal MelanomaElizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, et al.
Seminars in Arthritis and Rheumatism|November 10, 2018
Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experienceMeghan J Mooradian, Mazen Nasrallah, Justin F Gainor, et al.
Pageof 54